Several previous studies reported the important role of SRSF1-mediated alternative splicing in breast cancer (Xie et al., 2023; Kędzierska and Piekiełko-Witkowska, 2017; Yu and Fang, 2022; Anczuków et al., 2015). Here, SRSF1 is linked to breast carcinoma.